Dark Forest Capital Management’s Pacific Biosciences PACB Stock Holding History

Dark Forest Capital Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-43,698	Closed	-$365K	–	927
2023 Q3	$365K	Buy	43,698 +17,969	+70%	+$205K	0.03%	832
2023 Q2	$342K	Buy	+25,729	New	+$313K	0.03%	777
2022 Q1	–	Sell	-11,536	Closed	-$236K	–	1628
2021 Q4	$236K	Buy	+11,536	New	+$278K	0.09%	198

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Dark Forest Capital Management's PACB Position: Q4 2023 in Review

Dark Forest Capital Management sold out of Pacific Biosciences (PACB) in Q4 2023, closing a stake of 43,698 shares — an estimated $365K sold.

Dark Forest Capital Management first reported a position in PACB in Q4 2021 and held it in 3 quarters. The position peaked at $365K in Q3 2023. 274 funds tracked by Wall St. Rank hold PACB as of Q4 2023.

Dark Forest Capital Management reported no remaining Pacific Biosciences position as of Q4 2023 after selling out during the quarter.
Dark Forest Capital Management sold 43,698 Pacific Biosciences shares in Q4 2023, an estimated $365K.
Dark Forest Capital Management first reported a position in Pacific Biosciences in Q4 2021 and held it in 3 quarters.
Dark Forest Capital Management's Pacific Biosciences position peaked at $365K in Q3 2023.
274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2023.

Based on Dark Forest Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.